CBD is the fastest growing industry in the world, and an increasing number of farmers are beginning to see the benefits of growing hemp, from an economic point of view as well as being able to grow a product with many health benefits. Now that you have made the...
With the registration of our CBD Northwest and Midwest genetics in the European Common Catalogue, we have been getting a lot of attention from the industry and the media. See the latest article in Hemp Today:
BULGARIAN firm CBD Seed Europe has secured a place on the European seed register for two of its genetics which it says deliver record levels of cannabidiol.
After more than two and a half years of waiting our Midwest CBD and Northwest CBD strains have been officially added to the European Common Catalogue.
CBD Seed Europe were lucky enough to be invited to speak on the breeding and genetics panel where Francesco Folcarelli gave a speech and took part in the discussion.
Our most important takeaway from Canapa Mundi was that everyone seems to be on the same page as us that the way forward for the hemp sector is to move away from the gray legal framework that the industry has been based on to go towards a much clearer and well defined industry where everyone from farmer to Government agency is in complete understanding of what is and is not legal as it relates to CBD.
Our years of hard work and dedication has been celebrated by the European department of agriculture. Two of our high CBD, low THC strains have been registered into the EU seed catalog and received their Blue Label.
For years scientists have been trying to come up with new ways to cure male pattern baldness and as such the market has been flooded with products promising men and women a way to get their hair back. Well now a study from Canada published by the International Society...
As we wrote about in our last blog post, it had been found that CBDA and CBGA bind themselves to the spike proteins in the virus. New research based on a study on human participants has shown that users of CBD were less likely to contract the SARS-CoV-2 virus than...
Richard Van Breemen Ph.D and his team of researchers recently published their findings in The Journal of Natural Products. The study found that a number of Hemp derived compounds such as CBGA and CBDA can bind themselves to the SARS-CoV-2 spike protein, which blocks a critical step in the infection process in humans. This is the same process pharmaceutical companies use in the development of Covid-19 vaccines.